欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/1644/001
药品名称Gemcitabine Actavis 40 mg/ml, concentraat voor oplossing voor infusie
活性成分
    • gemcitabine hydrochloride 45.6 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Actavis Group PTC ehf. Reykjavikurvegur 76-78 220 Hafnarfjordur Iceland Splitting procedure: New splitted procedure number is PT/H/2035/001 (CMSs: ES and IT)
参考成员国 - 产品名称Netherlands (NL)
Gemcitabine Actavis 40 mg/ml, concentraat voor oplossing voor infusie
互认成员国 - 产品名称
    许可日期2010/08/31
    最近更新日期2022/12/15
    药物ATC编码
      • L01BC05 gemcitabine
    申请类型
    • TypeLevel1:Abridged
    • TypeLevel2:Initial Application
    • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
    • TypeLevel4:Chemical Substance
    • TypeLevel5:Prescription Only
    附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase